Polydatin exerts therapeutic effects on myelodysplastic syndrome by inhibiting the protein expression of oncogenes via hypermethylation in vitro
Abstract DNA methylation plays a critical role in myelodysplastic syndrome (MDS). Here, we aimed to observe the effects of polydatin (PD) on DNA methylation in MDS cells on a genome-wide scale and explore the underlying mechanisms, providing new evidence for PD as a novel hypermethylation agent. We...
Saved in:
| Main Authors: | Qingbing Zhou, Yuanbin Liang, Ruofan Chen, Hongzhi Wang, Qiuyue Guo, Li Liu, Xiaobo Zhu, Fengqin Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-01867-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New perspectives in the treatment of patients with intermediate-2 and high-risk myelodysplastic syndrome
by: E. V. Morozova, et al.
Published: (2022-11-01) -
Myelodysplastic syndromes: therapeutic problems and decisions (review)
by: S. V. Semochkin, et al.
Published: (2014-07-01) -
Epigenetic Modulation Directs Recovery Post LASIK and SMILE Surgery: An Experimental Study
by: Rohit Shetty, et al.
Published: (2025-02-01) -
Treatment of Vietnamese patients diagnosed with myelodysplastic neoplasms: Practical experience in a developing country
by: Quang Hao Nguyen, et al.
Published: (2025-01-01) -
Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports
by: Yunshuo Xiao, et al.
Published: (2024-12-01)